-
The anti-arrhythmic dronedarone has been approved by the FDA for maintenance of normal sinus rhythm in patients with a history of atrial fibrillation or atrial flutter.
-
The FDA has approved prasugrel, a new oral antiplatelet agent for use in preventing thrombosis in patients with acute coronary syndrome who are to be managed by angioplasty.
-
Two papers presented at the recent American Society of Clinical Oncology (ASCO) have brought to light to potential serious drug interaction between tamoxifen and several commonly used SSRI antidepressants.
-
The FDA has approved a single-dose formulation of Plan B, the emergency contraceptive previously available in a two-tablet dose.
-
-
Although still controversial, pooling of data from randomized trials suggests the neuroprotective benefit of magnesium sulfate in patients in preterm labor prior to 34 weeks of gestation.
-
This paper describes the results of an epidemiologic survey of the results of in-hospital cardiopulmonary resuscitation (CPR) in U.S. hospitals.
-
Patients who receive proton-pump inhibitors in the hospital are at increased risk for hospital-acquired pneumonia.
-
This meta-analysis of 12 clinical trials in adult patients with acute respiratory failure showed that extubation directly to non-invasive ventilation before weaning would normally have been attempted decreases mortality, ventilator-associated pneumonia, and length of stay especially for patients with COPD.
-
Based upon an increased incidence of heart failure with alpha 1-adrenergic antagonists treatment of hypertension, there has been concern about using alpha blockers for benign prostatic hypertrophy (BPH) in patients with heart failure, yet these drugs are highly efficacious for this common condition.